Evidence map›Paper›PMID 42270762›Full record

ArticleMolecular psychiatry2026

GluD1 is localized at cholinergic synapses and is an acetylcholine receptor.

Poojashree B Chettiar, Kishore Kumar S Narasimhan, Siddhesh S Sabnis, Spencer S Ericksen, Diane Choi, Yoland Smith, Shashank M Dravid

Abstract read
PubMed Publisher
In one paragraph

Article in Molecular psychiatry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Poojashree B Chettiar *Department of Psychiatry and Behavioral Sciences, Naresh K. Vashisht College of Medicine, Texas A&M University, 206, Olsen Blvd, Reynolds Medical Sciences Bldg., College Station, TX, 77845, USA.
Kishore Kumar S Narasimhan *Department of Psychiatry and Behavioral Sciences, Naresh K. Vashisht College of Medicine, Texas A&M University, 206, Olsen Blvd, Reynolds Medical Sciences Bldg., College Station, TX, 77845, USA.
Siddhesh S SabnisDepartment of Psychiatry and Behavioral Sciences, Naresh K. Vashisht College of Medicine, Texas A&M University, 206, Olsen Blvd, Reynolds Medical Sciences Bldg., College Station, TX, 77845, USA.
Spencer S EricksenDrug Development Core, Small Molecule Screening Facility, University of Wisconsin, Carbone Cancer Center, University of Wisconsin-Madison, Madison, WI, USA.ORCID http://orcid.org/0000-0003-4907-1160
Diane ChoiEmory National Primate Research Center, Emory University, Atlanta, GA, USA.
Yoland SmithEmory National Primate Research Center, Emory University, Atlanta, GA, USA.ORCID http://orcid.org/0000-0002-8700-878X
Shashank M DravidDepartment of Psychiatry and Behavioral Sciences, Naresh K. Vashisht College of Medicine, Texas A&M University, 206, Olsen Blvd, Reynolds Medical Sciences Bldg., College Station, TX, 77845, USA. smdravid@tamu.edu.ORCID http://orcid.org/0000-0002-9912-8148

Funding

Yerkes National Primate Research Center Role of type-I IFN in regulating COVID-19 induced inflammation and pathogenesisP51OD011132 · OD · EMORY UNIVERSITY · PI Joon Sup Lee · 2012 to 2026
$167.0M
UW COMPREHENSIVE CANCER CENTER SUPPORTP30CA014520 · NCI · UNIVERSITY OF WISCONSIN-MADISON · PI Justine Yang Bruce · 1985 to 2026
$142.6M
Trans-synaptic signaling complex in amygdala pain mechanismsR01NS118731 · NINDS · TEXAS A&M UNIVERSITY HEALTH SCIENCE CTR · PI DRAVID, SHASHANK MANOHAR, NEUGEBAUER, VOLKER · 2020 to 2024
$2.7M
Function of glutamate delta-1 receptorR01MH116003 · NIMH · TEXAS A&M UNIVERSITY HEALTH SCIENCE CTR · PI DRAVID, SHASHANK MANOHAR · 2018 to 2022
$1.9M
Structure-Function and Signaling of Glutamate Delta 1 in Pain MechanismR21NS132590 · NINDS · TEXAS A&M UNIVERSITY HEALTH SCIENCE CTR · PI DRAVID, SHASHANK MANOHAR · 2023 to 2023
$404k
NCI NIH HHS P30 CA014520NIMH NIH HHS R01 MH116003NINDS NIH HHS R01 NS118731NINDS NIH HHS R21 NS132590U.S. Department of Health & Human Services | National Institutes of Health (NIH) MH116003U.S. Department of Health & Human Services | National Institutes of Health (NIH) NS118731U.S. Department of Health & Human Services | National Institutes of Health (NIH) NS132590U.S. Department of Health & Human Services | National Institutes of Health (NIH) NS133338U.S. Department of Health & Human Services | National Institutes of Health (NIH) P51OD011132
6 · The paper itself

Abstract

The GluD1 receptor has many unusual features including expression at both excitatory and inhibitory synapses and a ligand binding domain capable of binding both D-serine and GABA. We have previously demonstrated that striatal GluD1 is critical for the regulation of behavioral flexibility, a phenotype dependent on the cholinergic system. Here, we found that GluD1 is enriched postsynaptically at cholinergic synapses in the mouse and monkey dorsal striatum. Further, loss of GluD1 reduces the abundance of cholinergic terminals, excitatory responses at cholinergic synapses as well as muscarinic receptor-induced plasticity. In addition, optogenetic stimulation of cholinergic interneurons or puff-application of ACh, in the presence of cholinergic and AMPA/GABA

Identifiers

PMID42270762

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.